Structural mass spectrometry in biologics discovery: advances and future trends-Reference-Cited by-同舟云学术

Structural mass spectrometry in biologics discovery: advances and future trends

Published:2012-12 Issue:23-24 Volume:17 Page:1323-1330
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Mo Jingjie,Tymiak Adrienne A.,Chen Guodong

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference63 articles.

1. Protein therapeutics: a summary and pharmacological classification;Leader;Nat. Rev. Drug Discov.,2008

2. Therapeutic antibodies for autoimmunity and inflammation;Chan;Nat. Rev. Immunol.,2010

3. Monoclonal antibodies: versatile platforms for cancer immunotherapy;Weiner;Nat. Rev. Immunol.,2010

4. Monoclonal antibodies for the treatment of severe asthma;Clienti;Curr. Allergy Asthma Rep.,2011

5. Maheshwari, S. (2011) Global protein therapeutics market: beefing up towards futuristic growth, www.pharmaphorum.com, online report, October 11, 2011.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Trisulfide on the Structure and Function of Different Antibody Constructs;Journal of Pharmaceutical Sciences;2023-10

2. NMR spectroscopy as a characterization tool enabling biologics formulation development;Journal of Pharmaceutical and Biomedical Analysis;2023-01

3. CE–MSMethods for the Characterization of Monoclonal Antibodies;Capillary Electrophoresis‐Mass Spectrometry for Proteomics and Metabolomics;2022-10-07

4. Differentiation and verification of monoclonal antibody therapeutics by integrating accurate mass analyses at intact, subunit and subdomain levels for forensic investigation;Forensic Chemistry;2022-09

5. Pharmacokinetic Assays;Bioanalytical Aspects in Biological Therapeutics;2022-07